The Bill & Melinda Gates Foundation shelled out $12 million on a low-cost inactivated polio vaccine manufacturing platform as supplies to international…

With €5 million in government funding, Themis and European collaborators have teamed up to create the newest Zika vaccine partnership.

Valneva is set to advance its Lyme disease vaccine candidate into clinical testing on both sides of the Atlantic.

The CDC has signed a $911 million contract to stockpile Emergent BioSolutions' BioThrax.

Themis closed a second round of financing worth €10 million, which will be used for its Chikungunya vaccine and to further a Zika-fighting candidate.

A team of scientists from Australia is making progress in developing a vaccine that protects the human “surfaces” most likely to encounter the virus first.

To get its dengue vaccine candidate into a 20,000-patient Phase III study, Takeda's vax unit had to stoke up a global growth spurt.

It’s another silver lining for drugmakers targeting HIV: Researchers have found promise in a combo of a Johnson & Johnson vaccine and a Gilead immune…

In a move that illustrates the stepped-up pace of Zika vaccine development, the Walter Reed Army Institute of Research is moving into human testing for its…

Infectious Diseases